For the Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor (Provisional) level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in BMT and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, UW and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
This is a year-long fellowship program with the goal of becoming an expert in BMT and immunotherapy. Rotations will include outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up, etc.) and immunotherapy services. The fellow will initially function as a primary provider with direct patient care responsibilities and will have increasing levels of clinical team leadership over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available for clinically focused research projects. University of Washington faculty engage in teaching, research, and service.
Anticipated start date: July 1, 2023
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Fred Hutch Immunotherapy Integrated Research Center (IIRC) seeks qualified candidates for its two-year Immunotherapy Physician Scientist Program. A successful applicant will be an MD or MD/PhD who is committed to pioneering major advances in medical practice through research. Applicants should be interested in an aspect of immuno-oncology relevant to the IIRC, as well as the development of therapies that modulate the immune system. Immunotherapy Physician Scientists will advance their academic careers by performing immuno-oncology research with access to state-of-the-art facilities and working with expert faculty mentors who are members in the Immunotherapy Integrated Research Center. Click here to view IIRC Faculty.
The IIRC will support the incumbent’s salary and lab expenses for two years of translational research training. However, the Physician Scientist is strongly encouraged to work with their mentor to apply for outside funding during their first year.
Fred Hutch is a world leader in immunotherapy. An exceptionally strong history of research in immunotherapy (FH immunotherapy) and bone marrow transplantation (FH transplantation) informs and guides progress towards the development of the next generation of curative treatments. Available resources include outstanding staff, facilities and the infrastructure necessary to support translational immunotherapy research:
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Warren Lab in the Program in Immunology in the Clinical Research Division and Global Oncology Program at the Fred Hutchinson Cancer Center has opportunities for up to two Bioengineering or Bioscience majors seeking to enhance their academic pursuits to participate in a short-term research internship under the supervision of a Staff Scientist.
Available projects include learning how to 1) investigate T-cell immunotherapy in a kidney tumor-on-a-chip microphysiological system; 2) perform CRISPR-Cas9 functional genomics screening to identify genes essential for T-cell mediated tumor killing and identify novel tumor antigens; and 3) functionally test the ability of T-cell receptors identified in patients with viral-induced malignancies such as Kaposi’s Sarcoma to recognize candidate antigens.
This is a 6-month unpaid internship position and students can earn course credits. It is ideal that you can begin in Spring or Summer quarter and attend the lab 16 hours per week.
Applicants should submit a cover letter including a brief description of your interest and plans (including when you can begin), a CV, transcript (unofficial is acceptable), and at least one reference.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
We are seeking multiple energetic, responsible interns to join our team, Office of Translational Research (OTR). STTR creates environments which enable researchers and clinicians to accelerate scientific discovery, translate it into cures and research advances which significantly improve patient outcomes and quality of life. We do this by focusing on three key areas:
Build seamless infrastructure to optimize and speed translational research
Strengthening tumor-specific translational research programs, and
Strengthening partnerships between Seattle-area and regional translational research institutions.
We are recruiting a Marketing/Communications intern to support STTR team members with development and implementation of outreach and communication strategies related to our infrastructure tools like:
Oncoscape
Specimen & Data Acquisition Network (SAN)
Seattle Translational Tumor Research
Specimen Data Management Tool
The goal of this internship is to increase awareness and use of all OTR offerings, across our over 500 clinical and research members. The work includes activities such as: one-on-one meetings with investigators, creation of “personas” (categories of users), outreach plans, and training and promotional materials. We are looking for full-time interns, 40 hours per week, from June 13th through August 12th, 2022 .
Minimum Qualifications
Preferred Qualifications
A cover letter stating your interest is highly recommended
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
For the Pediatric Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Pediatrics, Division of Hematology Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor (Provisional) level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in BMT and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the UW and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in BMT and Immunotherapy. This position will rotate through outpatient Hematopoietic Cell Transplantation (HCT) services (autologous and allogeneic transplant, immunotherapy, Long Term Follow Up) and on the inpatient transplant service initially as a primary care provider with increasing levels of independent patient care responsibility over the course of the year. Exposure to some of our unique clinical programs, including non-malignant transplantation, high risk leukemia, and survivorship, will be part of the learning experience as well. Approximately 75% of the year will be devoted to clinical activities with the remaining time available for the opportunity to participate in clinically focused research projects, which will be determined based on identification of mentors and projects. University of Washington faculty engage in teaching, research and service.
Anticipated start date: July 1, 2023
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
Your search for "" did not match any of our available careers. Please try another search term or combination of terms and filters.